Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Biotechnology and Applied Biochemistry|September 21, 2005
Nuclear proteins as gene-transfer vectorsAnnekathrin Haberland, Michael BöttgerChemical Biology & Drug Design|September 22, 2021
Lack of efficacy of mono-mode of action therapeutics in COVID-19 therapy - How the lack of predictive power of preclinical cell and animal studies leads developments astrayAnnekathrin Haberland, Johannes MüllerMini Reviews in Medicinal Chemistry|January 13, 2022
Aptamers Against COVID-19: An Untested OpportunityAnnekathrin Haberland, Johannes MüllerPharmaceutical Patent Analyst|November 19, 2013
The patent situation concerning the treatment of diseases associated with autoantibodies directed against G-protein-coupled receptorsAnnekathrin Haberland, Gerd Wallukat, Ingolf SchimkeTrends in Cardiovascular Medicine|July 21, 2012
Aptamer binding and neutralization of β1-adrenoceptor autoantibodies: basics and a vision of its future in cardiomyopathy treatmentAnnekathrin Haberland, Gerd Wallukat, Ingolf SchimkeAnalytical and Bioanalytical Chemistry|June 28, 2018
Antigen-free control wells in an ELISA set-up for the determination of autoantibodies against G protein-coupled receptors-a requisite for correct data evaluationAnnekathrin Haberland, Johannes Müller, Gerd Wallukat, et al.Heart Failure Reviews|December 18, 2010
Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicineSilvia Gilka Muñoz-Saravia, Annekathrin Haberland, Gerd Wallukat, et al.Case Reports in Oncology|April 10, 2013
Are Agonistic Autoantibodies against G-Protein Coupled Receptors Involved in the Development of Long-Term Side Effects of Tumor Chemotherapy?Annekathrin Haberland, Robson A S Santos, Ingolf Schimke, et al.Circulation Research|August 27, 2011
Aptamer neutralization of beta1-adrenoceptor autoantibodies isolated from patients with cardiomyopathiesAnnekathrin Haberland, Gerd Wallukat, Claudia Dahmen, et al.Pharmaceutical Research|September 1, 2005
Solid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorometry and Raman spectroscopyKatja Jores, Annekathrin Haberland, Siegfried Wartewig, et al.Pageof 4